Accuvest Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Accuvest Global Advisors's PFE Position: Q4 2023 in Review
Accuvest Global Advisors sold out of Pfizer (PFE) in Q4 2023, closing a stake of 15,938 shares — an estimated $529K sold.
Accuvest Global Advisors first reported a position in PFE in Q4 2014 and held it in 20 quarters. The position peaked at $1.33M in Q4 2022. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Accuvest Global Advisors reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Accuvest Global Advisors sold 15,938 Pfizer shares in Q4 2023, an estimated $529K.
- Accuvest Global Advisors first reported a position in Pfizer in Q4 2014 and held it in 20 quarters.
- Accuvest Global Advisors's Pfizer position peaked at $1.33M in Q4 2022.
- 2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Accuvest Global Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.